Company intelligence / Profile preview
Baylx
Irvine, California, United Statesbaylxinc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Baylx is a clinical-stage biopharmaceutical company developing novel stem cell therapeutics based on human umbilical cord tissue-derived mesenchymal stem cells. Its lead product BX-U001 has received US FDA IND clearance for rheumatoid arthritis and similar approval in China. The company also develops engineered MSCs for oncology and other indications such as IBD, liver cirrhosis, stroke, and COVID‑19. Their approach emphasizes the use of fresh rather than cryopreserved cells to maximize therapeutic potential. Early clinical results include regulatory clearances to initiate trials in RA and COVID‑19.[1][3]
- Therapeutic areas
- GastroenterologyRheumatologyOncologyNeurologyInfectious Diseases
- Modalities
- Human umbilical cord mesenchymal stem cells (hUC-MSC)Engineered hUC-MSCs (for malignant diseases)Stem cell therapy[1][4][5]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Strategic partnership with Beijing Beilai Biosciences Co. Ltd.[3]
Beyond the preview
Go deeper on Baylx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baylx.